Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Maltoni, M.
Right arrow Articles by Amadori, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maltoni, M.
Right arrow Articles by Amadori, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 12:443-450, 2001
© 2001 European Society for Medical Oncology


review-article

Palliative medicine and medical oncology

M. Maltoni1, and D. Amadori2

1Palliative Care Unit, Department of Oncology, City Hospital ‘L Pierantom’ Forli Italy
2Department of Oncology, City Hospital ‘L Pierantom’ Forli Italy

Correspondence to: Marco Maltoni, MD, Palliative Care Unit - Oncology Department, City Hospital ‘L. Pierantoni’, Via Forlamni, 34, 47100 Forli, Italy E-mail malto.ma{at}tin.it

Traditionally, medical oncology and palliative care have been considered two distinct and separate disciplines, both as regards treatment objectives and delivery times Palliative care in terminal stages, aimed exclusively at evaluating and improving quality of life, followed antitumor therapies, which concentrated solely on quantitative results (cure, prolongation of life, tumoral mass shrinkage) Over the years, more modern concepts have developed on the subject Medical oncology, dealing with the skills and strategic co-ordination of oncologic interventions from primary prevention to terminal phases, should also include assessment and treatment of patients' subjective needs Anticancer therapies should be evaluated in terms of both the quantitative and qualititative impact on patients' lives. Hence, the traditional view of palliative care has to be modified it constitutes a philosophical and methodological approach to be adopted from the early phases of illness. It is not the evident cultural necessity of integrating medical oncology with palliative medicine that may be a matter of argument, but rather the organizational models needed to put this combined care into practice should continuous care be guaranteed by a single figure, the medical oncologist, or rather by an interdisciplinary providers' team, including full-time doctors well-equipped for palliative care? In this paper the needs of cancer patients and the part that a complete oncologist should play to deal with such difficult and far-reaching problems are firstly described Then, as mild provocation, data and critical considerations on the ever increasing needs of palliative care, the present shortcomings in quality of life and pain assessment and management by medical oncologists, and the uncertain efficacy of interventional programmes to change clinical practice are described Finally, a model of therapeutic continuity is presented, which in our view is realistic and feasible- an Oncologic Programme as the unifying process, and the Comprehensive Cancer Centre, or the Oncologic Department, the delivering structure

comprehensive cancer centre, medical oncology, oncology department, palliative medicine


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Palliat MedHome page
A. Spoon, C Centeno, J Rodriguez, and W Ros
What keeps a palliative medicine physician so busy with patients? Time expenditure in palliative care
Palliative Medicine, March 1, 2009; 23(2): 181 - 181.
[PDF]


Home page
Ann OncolHome page
M. Maltoni
Opioids, pain, and fear
Ann. Onc., January 1, 2008; 19(1): 5 - 7.
[Full Text] [PDF]


Home page
Ann OncolHome page
D. Tassinari, M. Maltoni, and D. Amadori
Reply: Prediction of survival in terminally ill cancer patients: why we cannot avoid an evidence-based palliative medicine
Ann. Onc., August 1, 2002; 13(8): 1322 - 1323.
[Full Text] [PDF]


Home page
Ann OncolHome page
S. Tanneberger, I. Malavasi, P. Mariano, F. Pannuti, and E. Strocchi
Planning palliative or terminal care: the dilemma of doctors' prognoses in terminally ill cancer patients
Ann. Onc., August 1, 2002; 13(8): 1320 - 1322.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.